<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress.com" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
	xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
	>
<url><loc>https://harunrabbani.blog/2026/04/06/when-regulatory-conversations-quietly-rewrite-the-strategy/</loc><news:news><news:publication><news:name>Harun Rabbani</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-06T18:07:10+00:00</news:publication_date><news:title>When Regulatory Conversations Quietly Rewrite the Strategy</news:title><news:keywords>MedTech, technology, MedTech leadership, Leadership risk in regulated healthcare, Medical Devices, Regulatory Strategy, Venture Capital, entrepreneurship, Clinical Innovation, Healthtech Scapeup, MedTech Scaleup, tech, finance, startups</news:keywords></news:news><image:image><image:loc>https://harunrabbani.blog/wp-content/uploads/2026/03/image-3.png?w=150</image:loc></image:image></url></urlset>
